![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-desktop-headergif-63893.gif)
![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-mobile-headergif-78265.gif)
1. 195435-23-5
2. Trityl Valsartan
3. Triphyl Valsartan
4. (2s)-3-methyl-2-[pentanoyl-[[4-[2-(2-trityltetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic Acid
5. L-valine,n-(1-oxopentyl)-n-[[2'-[2-(triphenylmethyl)-2h-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-
6. L-valine, N-(1-oxopentyl)-n-[[2'-[2-(triphenylmethyl)-2h-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-
7. Schembl2930427
8. Bcp13064
9. Mfcd08460102
10. Akos024462383
11. Zinc150340405
12. Ds-7937
13. Cs-0103215
14. D84196
15. 435t235
16. 435v235
17. N-pentanoyl-n-((2'-(2-trityl-2h-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-l-valine
18. (2s)-3-methyl-2-[pentanoyl-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl] Methyl]amino]butanoic Acid;sodium
Molecular Weight | 677.8 g/mol |
---|---|
Molecular Formula | C43H43N5O3 |
XLogP3 | 9.8 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 14 |
Exact Mass | 677.33659025 g/mol |
Monoisotopic Mass | 677.33659025 g/mol |
Topological Polar Surface Area | 101 Ų |
Heavy Atom Count | 51 |
Formal Charge | 0 |
Complexity | 1030 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 1 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |